Lexeo Therapeutics, Inc. Common Stock (LXEO) NASDAQ
6.57
+0.125(+1.94%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
6.57
+0.125(+1.94%)
Currency In USD
| Market Cap | 5.33B |
| Enterprise Value | 5.27B |
| P/E Ratio | -35.23 |
| PEG Ratio | -1.13 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 14.28 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.37 |
| Return On Equity | -0.67 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -2.08M |
| EBITDA | -107.18M |
| Net Income | -99.96M |
| Diluted EPS | -1.86 |
| Total Cash | 63M |
| Total Cash/Share | 0.34 |
| Total Debt | 7.89M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 11.21 |
| Book Value Per Share | 0.46 |
| 52-Week Change | 178.18 |
| 52-Week High | 10.99 |
| 52-Week Low | 1.75 |
| Moving Average 50 Days | 6.61 |
| Moving Average 200 Days | 6.88 |
| Average Volume | 1.07M |
| Shares Outstanding | 74.09M |
| % Held by Institutions | 125.38 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |